Evidence map›Paper›PMID 37628801›Full record

ArticleInternational journal of molecular sciences2023

Beyond Motor Deficits: Environmental Enrichment Mitigates Huntington's Disease Effects in YAC128 Mice.

Evelini Plácido, Priscilla Gomes Welter, Ana Wink, Gabriela Duarte Karasiak, Tiago Fleming Outeiro, Alcir Luiz Dafre, Joana Gil-Mohapel, Patricia S Brocardo

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 5 countries.

Evelini PlácidoNeuroscience Graduate Program, Center of Biological Sciences, Federal University of Santa Catarina, Florianopolis 88040-900, SC, Brazil.ORCID 0000-0003-1969-8560
Priscilla Gomes WelterNeuroscience Graduate Program, Center of Biological Sciences, Federal University of Santa Catarina, Florianopolis 88040-900, SC, Brazil.ORCID 0000-0002-0278-7746
Ana WinkNeuroscience Graduate Program, Center of Biological Sciences, Federal University of Santa Catarina, Florianopolis 88040-900, SC, Brazil.
Gabriela Duarte KarasiakDepartment of Biochemistry, Center of Biological Sciences, Federal University of Santa Catarina, Florianopolis 88040-900, SC, Brazil.ORCID 0000-0002-2728-1530
Tiago Fleming OuteiroDepartment of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center Göttingen, 37075 Göttingen, Germany.ORCID 0000-0003-1679-1727
Alcir Luiz DafreNeuroscience Graduate Program, Center of Biological Sciences, Federal University of Santa Catarina, Florianopolis 88040-900, SC, Brazil.ORCID 0000-0001-8097-4611
Joana Gil-MohapelIsland Medical Program, Faculty of Medicine, University of British Columbia and Division of Medical Sciences, University of Victoria, Victoria, BC V8P 5C2, Canada.ORCID 0000-0003-4982-1662
Patricia S BrocardoNeuroscience Graduate Program, Center of Biological Sciences, Federal University of Santa Catarina, Florianopolis 88040-900, SC, Brazil.
Universidade Federal de Santa Catarina · BRGerman Center for Neurodegenerative Diseases · DEMorpho (United States) · USUniversity of British Columbia · CA

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior N/ADeutsche Forschungsgemeinschaft EXC 2067/1- 390729940National Council for Scientific and Technological Development N/AUniversity of Victoria (UVic, Victoria, BC, Canada) - São Paulo Research Foundation (FAPESP, São Paulo, SP, Brazil) SPRINT partnership UVic-FAPESP SPRINT 1/2018 Grant
6 · The paper itself

Abstract

Huntington's disease (HD) is a neurodegenerative genetic disorder characterized by motor, psychiatric, cognitive, and peripheral symptoms without effective therapy. Evidence suggests that lifestyle factors can modulate disease onset and progression, and environmental enrichment (EE) has emerged as a potential approach to mitigate the progression and severity of neurodegenerative processes. Wild-type (WT) and yeast artificial chromosome (YAC) 128 mice were exposed to different EE conditions. Animals from cohort 1 were exposed to EE between postnatal days 21 and 60, and animals from cohort 2 were exposed to EE between postnatal days 60 and 120. Motor and non-motor behavioral tests were employed to evaluate the effects of EE on HD progression. Monoamine levels, hippocampal cell proliferation, neuronal differentiation, and dendritic arborization were also assessed. Here we show that EE had an antidepressant-like effect and slowed the progression of motor deficits in HD mice. It also reduced monoamine levels, which correlated with better motor performance, particularly in the striatum. EE also modulated neuronal differentiation in the YAC128 hippocampus. These results confirm that EE can impact behavior, hippocampal neuroplasticity, and monoamine levels in YAC128 mice, suggesting this could be a therapeutic strategy to modulate neuroplasticity deficits in HD. However, further research is needed to fully understand EE's mechanisms and long-term effects as an adjuvant therapy for this debilitating condition.

Indexed as

Heredodegenerative Disorders, Nervous SystemHuntington DiseaseAminesAnimalsCell ProliferationCombined Modality TherapyMiceAminesenvironmental enrichmentHuntington’s diseasemonoaminesneurodegenerationneuronal plasticitytransgenic animal modelYAC128 mice

Identifiers

PMID37628801
PMCPMC10454852
OpenAlexW4385738232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.